| ozagrel ophthalmic (KCT-0809) / Teika, Ono Pharma, Kissei |
NCT02503189: A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome |
|
|
| Completed | 3 | | Japan | KCT-0809 ophthalmic solution, Placebo | Kissei Pharmaceutical Co., Ltd. | Dry Eye With Sjögren's Syndrome | 01/17 | | | |
NCT02503176: An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome |
|
|
| Terminated | 3 | | Japan | KCT-0809 ophthalmic solution | Kissei Pharmaceutical Co., Ltd. | Dry Eye With Sjögren's Syndrome | 05/17 | | | |
NCT02503163: A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome |
|
|
| Completed | 3 | | Japan | KCT-0809 ophthalmic solution | Kissei Pharmaceutical Co., Ltd. | Dry Eye With Sjögren's Syndrome | 10/17 | | | |
